Tr1 cells. In vivo, adoptive transfer of these DC leads lineage relationships of these subsets are complex, and to antigen-specific tolerance. Together, these data supa full picture has yet to emerge (Ardavin, 2003) . Neverport a model whereby, under steady-state conditions, theless, it is apparent that all three major CD11c hi subCD11c lo CD45RB ϩ DC are generated in situ at low fresets can be derived in vitro from bone marrow progenitor quency from locally found progenitor cells. However, cells and that the relative frequency of each is largely following parasitic infection, progenitor cells recruited dependent upon the prevailing cytokine environment. from the bone marrow and/or undergoing more rapid For example, whereas GM-CSF favors development of local self-renewal are more efficiently instructed by stroCD11c Figure 1B) . by 3 ϫ 10 3 CD11c hi DC by almost 50%, and when admixed at a 1:1 ratio, the degree of suppression increased By day 6 of culture, cells with a DC phenotype and staining for CD11c ( Figure 1C) (Figure 1D ). In contrast to GM-CSFderived DC, however, DC that developed on stromal CD45RB ϩ DC were isolated from culture, and the spontaneous accumulation of IL-10 mRNA was determined cells were uniformly CD45RB ϩ ( Figure 1E Wells were blocked with PBS containing 0.05% Tween and 5% milk powder overnight at 4ЊC. Serum from individual mice was added in Allogeneic Mixed Leukocyte Reaction serial dilutions in PBS and was incubated for 1 hr at 37ЊC. BiotinCell suspensions were made from the spleens of BALB/c mice.
conjugated rat anti-mouse IgG1 and IgG2a antibodies (Serotec) Splenocytes were depleted of CD11c ϩ cells by magnetic cell sorting were used at 1 or 2 g/ml, respectively, and were incubated for 1 hr by using anti-CD11c magnetic microbeads (Milteneyi Biotec) and a at 37ЊC for detection of serum IgG1 and IgG2a. To reveal binding MidiMACS separation column (Milteneyi Biotec). CD4 ϩ T cells were of biotinylated antibodies, plates were incubated for 30 min with subsequently purified from the CD11c Ϫ splenocytes by anti-CD4 strepavidin horseradish peroxidase (Serotec). Finally, plates were magnetic microbeads (Milteneyi Biotec) and a MidiMACS separation developed by using a TMB Substrate Reagent Set (BD Pharmingen), column (Milteneyi Biotec) following the manufacturers' protocol. Priand absorbance was measured at 450 nm by using a microplate mary mixed leukocyte reaction (MLR) were set up in flat-bottom reader (Molecular Devices). 96-well plates (TPP) with 3 ϫ 10 5 responder BALB/c CD4 ϩ T cells per well and variable numbers of allogeneic stimulator cells. All
